TP53 and age-related macular degeneration: The studies of Bhattacharya et al. suggest that age-related post-translational modifications of p53 limit its binding to its inhibitor MDM2, thereby activating caspase 3, inducing apoptosis, and thus triggering the pathogenesis that could lead to AMD.